Vanguard Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214M Buy
2,498,555
+244,446
+11% +$25.5M ﹤0.01% 1062
2026
Q2
$264M Sell
2,254,109
-160,667
-7% -$16.1M 0.01% 975
2026
Q1
$223M Buy
+2,414,776
New +$227M 0.01% 1009

Other funds holding MIRM

Vanguard Capital Management's MIRM Position: Q3 2026 in Review

Vanguard Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 11% in Q3 2026, buying an estimated $25.5M and bringing the position to 2,498,555 shares worth $214M. The position accounts for ﹤0.01% of the portfolio, ranked #1062.

Vanguard Capital Management first reported a position in MIRM in Q1 2026 and has held it in 3 quarters since. The position peaked at $264M in Q2 2026. 317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Vanguard Capital Management held 2,498,555 shares of Mirum Pharmaceuticals worth $214M as of Q3 2026.
  • Vanguard Capital Management bought 244,446 Mirum Pharmaceuticals shares in Q3 2026, an estimated $25.5M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1062 holding.
  • Vanguard Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Mirum Pharmaceuticals position peaked at $264M in Q2 2026.
  • 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.